MORGAN STANLEY - AKERO THERAPEUTICS INC ownership

AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 104 filers reported holding AKERO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of AKERO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$22,241,847
+23.5%
439,736
+14.0%
0.00%0.0%
Q2 2023$18,006,372
+31.6%
385,658
+7.8%
0.00%
+100.0%
Q1 2023$13,681,509
+20.6%
357,593
+72.8%
0.00%0.0%
Q4 2022$11,343,600
+72.4%
207,000
+7.1%
0.00%0.0%
Q3 2022$6,579,000
+399.2%
193,253
+38.8%
0.00%
Q2 2022$1,318,000
-44.4%
139,203
-16.7%
0.00%
Q1 2022$2,370,000
+61.4%
167,051
+140.6%
0.00%
Q4 2021$1,468,000
+14.8%
69,424
+21.3%
0.00%
Q3 2021$1,279,000
-42.5%
57,249
-36.1%
0.00%
Q2 2021$2,223,000
+153.8%
89,603
+196.8%
0.00%
Q1 2021$876,000
+17.9%
30,190
+4.9%
0.00%
Q4 2020$743,000
+239.3%
28,786
+306.2%
0.00%
Q3 2020$219,000
-93.5%
7,087
-94.8%
0.00%
-100.0%
Q2 2020$3,379,000
+12414.8%
135,590
+10534.5%
0.00%
Q1 2020$27,000
-81.8%
1,275
-80.9%
0.00%
Q4 2019$148,000
+289.5%
6,665
+301.0%
0.00%
Q3 2019$38,000
+1800.0%
1,662
+1562.0%
0.00%
Q2 2019$2,0001000.00%
Other shareholders
AKERO THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
ATP Life Science Ventures, L.P. 5,830,203$179,512,00024.20%
venBio Partners LLC 2,444,311$75,260,00011.44%
Versant Venture Management, LLC 777,727$23,946,0004.38%
Redmile Group, LLC 2,336,357$71,936,0001.32%
Vivo Capital, LLC 571,833$17,607,0001.02%
Cormorant Asset Management, LP 859,550$26,466,0001.02%
Boxer Capital, LLC 831,495$25,602,0000.88%
Integral Health Asset Management, LLC 85,000$2,617,0000.80%
EAM Global Investors LLC 49,718$1,531,0000.56%
Crawford Lake Capital Management, LLC 43,826$1,349,0000.56%
View complete list of AKERO THERAPEUTICS INC shareholders